Recursion Pharmaceuticals (RXRX) is back in focus after management detailed AI driven gains in drug discovery, including 25 new targets identified at once, as investors look ahead to an earnings ...

Stranger Things' animated spinoff 'Tales From '85' is a depressing, cynical attempt to preserve the Netflix hit in pixels.

The big SpaceX IPO is coming, and it could probably become the new, more exciting way to bet on Elon Musk’s vision of the ...

As Project Hail Mary grips audiences with its mix of science and survival, these five gripping novels offer more journeys ...

The reason this matters so much right now is that AI and humans are fundamentally different kinds of intelligence. Despite ...

A new datamine of Borderlands 4 provides some some pretty compelling evidence of the next DLC Vault Hunter coming in Story ...

Where centralised societies excel at extraction, African fractal systems allow for circulation, reciprocity and return ...

Jayne Ann Phillips looks back without imposing a moral; Maria Semple keeps things moving before one can form. A memoir and a ...

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

According to TipRanks.com, Blum is a 4-star analyst with an average return of 9.1% and a 40.2% success rate. Blum covers the Healthcare sector, focusing on stocks such as Artiva Biotherapeutics, Inc., ...

View Recursion Pharmaceuticals, Inc. Class A RXRX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...